GlassScriptPhysician profile
Chasity M Sisson
NPI 1992983829
$2,326.39
in general payments reported to CMS, 2019-2025
24 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $422 · 2022: $393 · 2023: $636 · 2024: $775 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $623.34 | 2021-2025 | |
| Novo Nordisk INC | $438.53 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $278.28 | 2021-2024 | Mounjaro |
| Mylan Specialty L.P. | $174.41 | 2022-2024 | Yupelri |
| Dexcom, INC. | $154.60 | 2021-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $101.21 | 2023-2025 | |
| Idorsia Pharmaceuticals US INC | $92.68 | 2024 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.77 | 2023-2024 | Ofev, Jardiance |
| Astrazeneca Pharmaceuticals LP | $61.18 | 2021-2024 | Airsupra |
| Amarin Pharma, INC. | $35.95 | 2021 | |
| Amgen INC. | $33.26 | 2021-2022 | |
| Exact Sciences Corporation | $32.30 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.13 | 2022-2023 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $28.76 | 2024-2025 | |
| Glaxosmithkline, LLC. | $25.59 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $20.48 | 2024 | Sunosi |
| Neos Therapeutics, LP | $18.92 | 2024 | Adzenys Xr-Odt |
| Eisai INC. | $17.82 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.03 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.96 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.13 | 2021 | |
| Medtronic, INC. | $14.21 | 2023 | Intellis Adaptivestim |
| Janssen Pharmaceuticals, INC | $12.56 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chasity Sisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.